These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer. Cubillos-Ruiz JR; Bettigole SE; Glimcher LH Cell; 2017 Feb; 168(4):692-706. PubMed ID: 28187289 [TBL] [Abstract][Full Text] [Related]
4. Endoplasmic reticulum stress regulates tumor growth and anti-tumor immunity: a promising opportunity for cancer immunotherapy. Mohamed E; Cao Y; Rodriguez PC Cancer Immunol Immunother; 2017 Aug; 66(8):1069-1078. PubMed ID: 28577085 [TBL] [Abstract][Full Text] [Related]
5. Cancer-induced systemic myeloid dysfunction: Implications for treatment and a novel nanoparticle approach for its correction. Alvarez R; Oliver L; Valdes A; Mesa C Semin Oncol; 2018 Jan; 45(1-2):84-94. PubMed ID: 30318088 [TBL] [Abstract][Full Text] [Related]
6. Myelopoiesis during Solid Cancers and Strategies for Immunotherapy. Wildes TJ; DiVita Dean B; Flores CT Cells; 2021 Apr; 10(5):. PubMed ID: 33919157 [TBL] [Abstract][Full Text] [Related]
7. T-cell-Secreted TNFα Induces Emergency Myelopoiesis and Myeloid-Derived Suppressor Cell Differentiation in Cancer. Al Sayed MF; Amrein MA; Bührer ED; Huguenin AL; Radpour R; Riether C; Ochsenbein AF Cancer Res; 2019 Jan; 79(2):346-359. PubMed ID: 30389698 [TBL] [Abstract][Full Text] [Related]
8. Elevated endoplasmic reticulum stress reinforced immunosuppression in the tumor microenvironment via myeloid-derived suppressor cells. Lee BR; Chang SY; Hong EH; Kwon BE; Kim HM; Kim YJ; Lee J; Cho HJ; Cheon JH; Ko HJ Oncotarget; 2014 Dec; 5(23):12331-45. PubMed ID: 25514597 [TBL] [Abstract][Full Text] [Related]
9. A stressful microenvironment: opposing effects of the endoplasmic reticulum stress response in the suppression and enhancement of adaptive tumor immunity. Rausch MP; Sertil AR Int Rev Immunol; 2015 Mar; 34(2):104-22. PubMed ID: 25774773 [TBL] [Abstract][Full Text] [Related]
10. Glutamine Deprivation Promotes the Generation and Mobilization of MDSCs by Enhancing Expression of G-CSF and GM-CSF. Sun HW; Wu WC; Chen HT; Xu YT; Yang YY; Chen J; Yu XJ; Wang Z; Shuang ZY; Zheng L Front Immunol; 2020; 11():616367. PubMed ID: 33603745 [TBL] [Abstract][Full Text] [Related]
11. Myelopoiesis in the Context of Innate Immunity. Mitroulis I; Kalafati L; Hajishengallis G; Chavakis T J Innate Immun; 2018; 10(5-6):365-372. PubMed ID: 29874678 [TBL] [Abstract][Full Text] [Related]
12. Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. Dysthe M; Parihar R Adv Exp Med Biol; 2020; 1224():117-140. PubMed ID: 32036608 [TBL] [Abstract][Full Text] [Related]
14. Generation of Myeloid Cells in Cancer: The Spleen Matters. Wu C; Hua Q; Zheng L Front Immunol; 2020; 11():1126. PubMed ID: 32582203 [TBL] [Abstract][Full Text] [Related]
15. Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity. Mitroulis I; Ruppova K; Wang B; Chen LS; Grzybek M; Grinenko T; Eugster A; Troullinaki M; Palladini A; Kourtzelis I; Chatzigeorgiou A; Schlitzer A; Beyer M; Joosten LAB; Isermann B; Lesche M; Petzold A; Simons K; Henry I; Dahl A; Schultze JL; Wielockx B; Zamboni N; Mirtschink P; Coskun Ü; Hajishengallis G; Netea MG; Chavakis T Cell; 2018 Jan; 172(1-2):147-161.e12. PubMed ID: 29328910 [TBL] [Abstract][Full Text] [Related]
16. Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation. Yang Y; Li C; Liu T; Dai X; Bazhin AV Front Immunol; 2020; 11():1371. PubMed ID: 32793192 [TBL] [Abstract][Full Text] [Related]
17. Innate immune mediators in cancer: between defense and resistance. Berraondo P; Minute L; Ajona D; Corrales L; Melero I; Pio R Immunol Rev; 2016 Nov; 274(1):290-306. PubMed ID: 27782320 [TBL] [Abstract][Full Text] [Related]
19. Endoplasmic Reticulum Stress Responses in Intratumoral Immune Cells: Implications for Cancer Immunotherapy. Song M; Cubillos-Ruiz JR Trends Immunol; 2019 Feb; 40(2):128-141. PubMed ID: 30612925 [TBL] [Abstract][Full Text] [Related]
20. Tumor-derived osteopontin suppresses antitumor immunity by promoting extramedullary myelopoiesis. Kim EK; Jeon I; Seo H; Park YJ; Song B; Lee KA; Jang Y; Chung Y; Kang CY Cancer Res; 2014 Nov; 74(22):6705-16. PubMed ID: 25273090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]